In-hoo Kim
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
The immune sensitivity caused by DUSP11, an RNA 5'-end maturation phosphatase, is adjusted by a human non-coding RNA, nc886.
Journal: Cellular and molecular life sciences : CMLS
Published: July 22, 2024
Adenovirus expressing nc886, an anti-interferon and anti-apoptotic non-coding RNA, is an improved gene delivery vector.
Journal: Molecular therapy. Nucleic acids
Published: April 04, 2024
Complexation of drug and hapten-conjugated aptamer with universal hapten antibody for pancreatic cancer treatment.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 10, 2022
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus.
Journal: Molecular therapy oncolytics
Published: September 03, 2021
Nc886, a Novel Suppressor of the Type I Interferon Response Upon Pathogen Intrusion.
Journal: International journal of molecular sciences
Published: January 26, 2021
ELAC2, an Enzyme for tRNA Maturation, Plays a Role in the Cleavage of a Mature tRNA to Produce a tRNA-Derived RNA Fragment During Respiratory Syncytial Virus Infection.
Journal: Frontiers in molecular biosciences
Published: September 24, 2020
Mechanism mediated by a noncoding RNA, nc886, in the cytotoxicity of a DNA-reactive compound.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 06, 2019
Epigenetic regulation of noncoding RNA transcription by mammalian RNA polymerase III.
Journal: Epigenomics
Published: January 24, 2017
Dynamic relocalization of NHERF1 mediates chemotactic migration of ovarian cancer cells toward lysophosphatidic acid stimulation.
Journal: Experimental & molecular medicine
Published: August 04, 2016
nc886, a non-coding RNA and suppressor of PKR, exerts an oncogenic function in thyroid cancer.
Journal: Oncotarget
Published: June 16, 2016
An aptamer-antibody complex (oligobody) as a novel delivery platform for targeted cancer therapies.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: September 24, 2015
Last Updated: 09/26/2026